Loading...
Loading...
A validated 6-variable risk score for predicting major hemorrhagic complications in patients with venous thromboembolism (VTE — deep vein thrombosis or pulmonary embolism) who are receiving anticoagulation therapy. Derived from the RIETE (Registro Informatizado de la Enfermedad TromboEmbólica) registry, the score helps quantify the risk-benefit balance of anticoagulation, guide intensity and duration of therapy, and identify patients requiring close monitoring.
Recent Major Bleeding (Within 30 Days Prior to VTE Diagnosis)
Creatinine > 1.2 mg/dL (> 106 µmol/L)
Anemia at Presentation
Active Cancer
Clinically Overt PE at Presentation (vs. DVT Alone)
Age > 75 Years
Awaiting input
Fill in the parameters to see your result